Itraconazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Itraconazole Prices June 2023
|
Product
|
Category | Region | Price |
|---|---|---|---|
| Itraconazole | Chemical | USA | 376091 USD/MT |
| Itraconazole | Chemical | China | 350378 USD/MT |
| Itraconazole | Chemical | Germany | 374795 USD/MT |
In the second quarter of 2023, the price of the itraconazole in the United States reached 376091 USD/MT by June. Similarly, in China, the itraconazole prices hit 350378 USD/MT in the same month. Germany also saw itraconazole prices reaching 374795 USD/MT during Q2 2023.
Itraconazole Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Itraconazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of itraconazole pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of itraconazole at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of itraconazole price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing itraconazole price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Itraconazole Market Analysis
The global itraconazole market size reached US$ 639.7 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 763.2 Million, at a projected CAGR of 2.00% during 2023-2032.
The growing ability of individuals to afford health care costs and the increased number of clinical trials conducted by government organizations are mainly driving the itraconazole market. For instance, at eBioMedicine, numerous drug libraries were screened with a high-throughput screening test for in vitro activity against the SARS-CoV-2 virus. The drug screening revealed the antiviral activity of itraconazole and its metabolite hydro-itraconazole as compared to the in vitro antiviral activity of hydroxychloroquine. Moreover, Alembic Pharmaceuticals Ltd announced that the company has received approval from US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Itraconazole capsules. Companies are also developing new formulations of itraconazole in the form of tablets and capsules. They are commercially available in both oral and IV forms. In addition, itraconazole is widely used for treating diseases like histoplasmosis, aspergillosis, and onychomycosis, among others, because of its effectiveness against the pathogen and lesser side effects when compared to conventional therapeutic agents. For instance, Gnova Biotech, one of the ISO-certified companies that manufacture pharma drugs according to the guidelines of WHO and GMP, introduced Itonaz-100, which is the fusion of itraconazole capsules that are used to treat fungal infections of several parts of the body, such as toenails, fingernails, throat, and mouth. In addition to this, Eraas International, one of the leading and trusted pharmaceutical firms in India, launched ITRAS-100, which stops the growth of fungi by destroying their cell membrane. Furthermore, the general correlations of high glucose levels with high cellular damage cause a number of infectious and non-infectious skin diseases. Therefore, diabetes patients are at a higher risk for developing different kinds of fungal infections, and onychomycosis is one of the main infections that affect these patients. According to an article published in the Journal of Fungi in August 2022, when a group of people was studied for skin and nail disorders in diabetic patients, onychomycoses were found common in critically ill diabetic patients.
Itraconazole News
The report covers the latest developments, updates, and trends impacting the global itraconazole market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in itraconazole production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the itraconazole price trend.
Latest developments in the Itraconazole industry:
- In August 2023, Pulmatrix announced a study showing low risk of drug interactions with its inhaled itraconazole PUR1900 for treating allergic bronchopulmonary aspergillosis (ABPA) in asthma patients, avoiding side effects of oral itraconazole. PUR1900 is currently in Phase 2 clinical trials for ABPA.
- In May 2024, Johnson & Johnson announced that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with potential for an additional milestone payment.
Product Description
Itraconazole is an antifungal medication effective in treating a variety of fungal infections. It belongs to the azole family of antifungals and works by inhibiting fungus growth in the body. Moreover, itraconazole is available in several forms, including capsules, oral solutions, and intravenous solutions. The drug is in the category of broad-spectrum antifungal agents targeting yeasts and molds. It is specifically active against Aspergillus and Candida strains. Some of itraconazole’s characteristics are its high oral bioavailability, used orally as opposed to intravenously, and its ability to conjugate to skin and nail structures used for dermatological and nail infections. However, it should be taken under medical guidance due to potential side effects and interactions with other drugs.
Regional Coverage
The report provides a detailed analysis of the itraconazole market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the itraconazole price trend.
Global Itraconazole Price
The report offers a holistic view of the global itraconazole pricing trends in the form of itraconazole price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of itraconazole but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed itraconazole demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Itraconazole Price
European Itraconazole prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed itraconazole price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Itraconazole Price
The analysis of Itraconazole prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific itraconazole historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Itraconazole Price
The report explores the Itraconazole pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on itraconazole prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Itraconazole Price
The Itraconazole pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This itraconazole price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Itraconazole Price
The analysis of itraconazole prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Itraconazole |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Itraconazole Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of itraconazole pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting itraconazole price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The itraconazole price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Inquire Before Buying
Speak to an Analyst
Request Brochure
Request Customization
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
